Shares of Sun Pharmaceuticals Industries hit an over four-year high as they rallied 9 per cent to Rs 767.50 on the BSE in intra-day trade on Friday after the company reported strong results for the June quarter (Q1FY22), with adjusted net profit up 73 per cent year-on-year (YoY) at Rs 1,979 crore, mainly due to robust operational performance. The reported net profit for Q1FY22 was at Rs 1,444 crore.
The stock of the drugmaker was trading at its highest level since October 2016. It recorded its sharpest intra-day rally in the past 15 months. Earlier, on April 7, 2020, it had zoomed 11.6 per cent in intra-day trade on the BSE, data shows.